iBio, Inc. (IBIO) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $99 million, iBio, Inc. is a micro-cap company. The stock currently trades at $2.71, down 4.08% today, with a 52-week range of $0.56–$6.89.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-1.75 | $-1.75 | +73.1% | |
| 2024 | $-6.50 | $-6.50 | -22.4% | |
| 2023 | $-5.31 | $-5.31 | +8.1% | |
| 2022 | $-5.78 | $-5.78 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-06-30 | 2025-09-05 | 0001558370-25-011888 | SEC ↗ |
| 2024-06-30 | 2024-09-20 | 0001420720-24-000038 | SEC ↗ |
| 2023-06-30 | 2023-09-27 | 0001420720-23-000045 | SEC ↗ |
| 2022-06-30 | 2022-10-11 | 0001420720-22-000064 | SEC ↗ |
| 2021-06-30 | 2021-09-28 | 0001558370-21-012819 | SEC ↗ |
| 2020-06-30 | 2020-10-13 | 0001104659-20-114567 | SEC ↗ |
| 2019-06-30 | 2019-08-26 | 0001144204-19-041659 | SEC ↗ |
| 2018-06-30 | 2018-09-18 | 0001144204-18-049866 | SEC ↗ |
| 2017-06-30 | 2017-09-15 | 0001144204-17-048249 | SEC ↗ |
| 2016-06-30 | 2016-10-13 | 0001144204-16-127993 | SEC ↗ |
| 2015-06-30 | 2015-10-13 | 0001144204-15-059224 | SEC ↗ |
| 2014-06-30 | 2014-09-29 | 0001144204-14-058454 | SEC ↗ |
| 2013-06-30 | 2013-09-30 | 0001144204-13-053105 | SEC ↗ |
| 2012-06-30 | 2012-10-12 | 0000930413-12-005714 | SEC ↗ |
| 2011-06-30 | 2011-09-29 | 0000930413-11-006342 | SEC ↗ |
| 2010-06-30 | 2010-10-13 | 0000930413-10-005065 | SEC ↗ |
| 2009-06-30 | 2009-09-28 | 0001420720-09-000028 | SEC ↗ |
| 2008-06-30 | 2008-09-29 | 0001420720-08-000025 | SEC ↗ |